Crucial information people taking Xarelto should know

Posted on Monday, September 29th, 2014 at 11:51 am    

The pharmaceutical Xarelto is taken by many to lower their risk of blood clots and stroke. However, there are many dangerous complications associated with this drug. If you are taking Xarelto or wish to cease taking it, it is important to remain aware of the following:

  • If you wish to stop taking Xarelto, consult with your prescribing doctor to discuss any possible risks.
  • Sometimes, abruptly ceasing to take Xarelto may lead to an increased risk of blood clots in different parts of the body.
  • Those who medicate with Xarelto may experience easy bruising or uncontrollable bleeding that is serious and sometimes fatal.
  • People taking Xarelto may need to take other medicines when complications such as severe bleeding occur.

Sadly, people medicating with Xarelto may experience other side effects that could lead to severe gastrointestinal bleeding. If you or a loved one has suffered unduly from taking Xarelto, you may be eligible to pursue compensation from the drug maker. Learn more about your legal options from the attorneys of Williams Kherkher by calling (800) 220-9341 today.


Understanding the three classifications of diarrhea

Posted on Monday, September 29th, 2014 at 11:43 am    

Diarrhea is a condition causing watery and loose feces and typically lasts for several days. Although this condition can result from several different causes, medical professionals typically group this condition into three different categories:

  • Osmotic: when food consumed causes the bowels to draw water from the body
  • Secretory: when an infection or drug causes the body to release water into the bowels
  • Exudative: caused by infections or inflammatory bowel diseases; may result in blood or pus

Unfortunately, diarrhea is one of the side effects linked to Benicar, which people use to lower their blood pressure. If you think your severe intestinal problem is a result of using the potentially dangerous drug, the lawyers at Williams Kherkher may represent you in your pursuit of financial compensation from negligent drug manufacturers. Speak with us today by calling (800) 220-9341, and find out how we may help you get the funds you need from treatment from those liable.


Women at a higher risk of developing gallstones

Posted on Monday, September 29th, 2014 at 11:23 am    

According to medical experts, women have a higher chance of developing gallstones compared to men, U-T San Diego reported on September 11.

Experts from the American College of Gastroenterology stated that women aged 20 to 60 have a risk three times greater of developing gallstones compared to men. However, there are other risk factors for women that may influence the likelihood of a gallstone, including ethnicity, family history, numbers of pregnancies, and other medical conditions. The majority of women reportedly are unaware that they have already developed gallstones, and this ignorance can become dangerous if a gallbladder attack occurs. Gallstones, the stone-like deposits in the gallbladder, can only be removed through surgery.

Sadly, many women also suffer gallbladder complications as a result of taking Yasmin and Yaz birth control pills. If this happens to you or to a loved one, a lawyer may help you get your much needed treatment funds for your recovery. Speak with the lawyers of Williams Kherkher today by calling (800) 220-9341 to find out how we may work for you.


Woman penned a memoir about growing up with cleft defects

Posted on Monday, September 29th, 2014 at 11:14 am    

A Brigham City woman who was once a victim of bullying due to her oral cleft defects wrote about her experiences in a self-published book to help parents who have kids with cleft defects, the Standard Examiner reported on September 15.

Amy Jo Wilde released a book entitled White Bees in which she recounted the hardships of being bullied growing up due to her double cleft lip and palate. Aside from being bullied, Wilde narrated the emotional pain she suffered and how she underwent surgery several times. The book, according to Wilde, is intended to help mothers cope with the daily challenges of having children with cleft lip and palate.

Aside from expensive treatments, individuals affected by cleft defects unfortunately have to undergo emotional difficulties caused by other people. If you believe that the congenital defects of a loved one resulted from Topamax being taken during pregnancy, the lawyers at Williams Kherkher may represent you. Find out how we may help you hold negligent drug makers liable by calling (800) 220-9341 today.


Recreational anglers lost $585M in potential earnings during BP oil spill year

Posted on Friday, September 26th, 2014 at 11:27 am    

A recent University of Florida study showed that recreational anglers who fish in the Gulf of Mexico lost $585 million in potential earnings due to the Deepwater Horizon oil spill, making the group potentially eligible for financial compensation from BP, Highlands Today reported on September 17.

In the same vein, BP agreed in 2012 to pay $2.3 billion to commercial fishermen, seafood boat captains and crew, seafood vessel owners, and oyster leaseholders.

UF Institute of Food and Agricultural Sciences faculty member Sherry Larkin said the monetary losses of recreational anglers were significant and noted that trustees could attempt to ask for compensation for all users of the Gulf, a public resource, due to the massive effect the oil spill had on fisheries.

Williams Kherkher has successfully filed claims against BP in regards to the Deepwater Horizon oil spill and may be able to help you. Call our offices at (800) 220-9341 today to discuss your claim and legal options.


New drug to treat metastatic melanoma

Posted on Tuesday, September 23rd, 2014 at 12:32 pm    

A new treatment to help cure metastatic melanoma – a quick-spreading form of skin cancer that manifests as mole-like marks in the body – has been developed through the drug Keytruda and is intended to bolster the body’s immune system, The Jewish Press reported on September 16.

The drug is currently undergoing clinical trials at Tel Aviv’s Sheba Hospital at Tel Hashomer Medical Center in Israel. Around 250 people diagnosed with melanoma in Israel suffer from metastatic tumors every year. Ella Institute for Melanoma at Sheba Hospital head Professor Jacob Schachter said Keytruda can also be used in the treatment for other types of cancer. The new drug has recently been approved by the United States Food and Drug Administration.

The drug Viagra, usually marketed towards adult men, has been known to cause melanoma, among other complications. If you or someone you love has developed skin cancer or has otherwise been negatively affected while taking Viagra, the attorneys at Williams Kherkher may help you pursue financial compensation for any expenses or suffering. Call our offices at 800-220-9341 today to learn more.


New hip/knee implant “innovations” less effective

Posted on Tuesday, September 23rd, 2014 at 12:19 pm    

A recent study published in the BMJ, previously the British Medical Journal, revealed that newer models of hip and knee implant devices are more prone to early failure than older models despite allegations that they are more advanced, DrugWatch reported on September 17.

To be specific, newly-released hip implant devices such as the DePuy ASR Hip and the Zimmer NexGen Knee implant have been verified to have above-average failure rates. The failure of these products often results in patients having to undergo follow-up revision surgeries, which adds to expenses and may affect their health.

The study, led by New York’s Weill Cornell Medical College associate professor Art Sedrakyan, was inspired by the large number of metal-on-metal hip implant failures in recent years. Sedrakyan and his team collaborated with the U.S. Food and Drug Administration to gather data from 118 previous studies.

The attorneys at Williams Kherkher are committed to giving legal counsel and representation to DePuy hip implant users who have encountered negative side effects or have had premature product failure. Call our offices today at 800-220-9341 to set up an appointment with members of our legal team.


Wearable kidney dialysis machine to be tested with humans

Posted on Tuesday, September 23rd, 2014 at 12:06 pm    

A portable kidney dialysis machine that can be worn as a belt around the waist has been developing over the past ten years, and the University of Washington has recently been approved by the FDA to test the device on humans, MY Northwest reported on September 16.

The product is a 10-pound, battery-operated device called the Wearable Artificial Kidney (WAK). Dialysis treatments must be undertaken three times a week, with sessions that last three to four hours. The conception of the WAK is a feat, as it greatly increases the convenience for dialysis patients who spend a significant amount of time driving to and from hospitals or other facilities for treatment, where they then sit for even longer.

Fresenius Medical Group’s GranuFlo is a well-known dialysis concentrate that many people use. However, GranuFlo has encountered legal problems due to its prevalent and often dangerous side effects. If you have experienced negative side effects from using GranuFlo, contact the attorneys at Williams Kherkher, who may help you hold the negligent manufacturer financially accountable for any damages. Call our offices at 800-220-9341 today to discuss your case.


Stroke risk in older women may be lessened by foods rich in potassium

Posted on Monday, September 22nd, 2014 at 12:07 pm    

A study suggest that older women have a lesser risk of suffering stroke if they eat foods rich in potassium, an article of the Washington Post stated on September 4.

Senior researcher and author Sylvia Wassertheil-Smoller and other colleagues at Albert Einstein College of Medicine found that women who consumed the largest amount of potassium reduced their general stroke risk by 12 percent, 27 percent if they did not have hypertension. Only 2.8 percent of the experimental population was consuming the government recommended 24,700 milligrams of potassium a day; some are worried that this sample reflects similar percentages at a national level. Because of this, the author suggests that women, regardless of age, need to be more cognizant of including more potassium rich foods to their diet.

Many factors can contribute to stroke. Taking Yasmin and Yaz birth control can put you at a greater risk. If you were taking these pills and suffered a stroke, the legal team of Williams Kherkher may possibly work for you to get your much needed treatment funds. Get in touch with our lawyers today by calling (800) 220-9341 to learn more about your options.


Researchers understand cleft lip/palate defects by studying chickens

Posted on Monday, September 22nd, 2014 at 11:35 am    

A group of researchers recently found that humans tend to develop congenital defects like cleft lip and palate through genetic mutations similar to that of chickens, an article of Futurity stated on September 3.

Researchers from several different universities in the U.S. reportedly studied chickens predicted to have several congenital problems. The researchers discovered that the talpid2 gene was responsible for several physical malformations including cleft lip and palate. They found that the “cilia” found in chickens and humans played a factor in the development of congenital defects. Animal science Professor Mary Delany stated that their discovery can be used to further understand birth defects in humans around the world.

While researchers are still investigating underlying causes of cleft lip and palate, there seems to be higher incidences in children that  have been exposed to Topamax in the womb. If you believe this may be the reason for your loved one’s condition, getting a lawyer’s help is crucial especially if your baby will need extensive corrective medical procedures. Find out how the legal team of Williams Kherkher may represent you today by calling (800)220-9341.


1 2 3 34

Williams Kherkher | 8441 Gulf Fwy #600 | Houston, TX 77017 | Phone: (713) 230-2200 | Toll Free: (800) 220-9341 | Directions